Drug Ophthalmology

Akten

Payments companies reported to CMS as associated with Akten. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$677Kassociated payments (2023-2025)
2clinicians with associated payments
1company reporting

By year

2023 $421K
2024 $256K

Payments reported as associated with Akten, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Retina Specialist $339K
Uveitis and Ocular Inflammatory Disease $339K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Akten

These are the largest totals companies reported as associated with Akten. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Elias Reichel Boston, MA Uveitis and Ocular Inflammatory Disease $338,580.89
Brandon Busbee Nashville, TN Retina Specialist $338,580.89

Prescribed Akten?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.